JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Performance of a sequencing batch biofilm reactor for the treatment of pre-oxidized sulfamethoxazole solutions.

A combined strategy of a photo-Fenton pretreatment followed by a Sequencing Batch Biofilm Reactor (SBBR) was evaluated for total C and N removal from a synthetic wastewater containing exclusively 200 mg L(-1) of the antibiotic Sulfamethoxazole (SMX). Photo-Fenton reaction was optimized at the minimum reagent doses in order to improve the biocompatibility of effluents with the subsequent biological reactor. Consequently, the pretreatment was performed with two different initial H(2)O(2) concentrations (300 and 400 mg L(-1)) and 10 mg L(-1) of Fe(2+). The pre-treated effluents with the antibiotic intermediates as sole carbon source were used as feed for the biological reactor. The SBBR was operated under aerobic conditions to mineralize the organic carbon, and the Hydraulic Retention Time (HRT) was optimized down to 8h reaching a removal of 75.7% of the initial Total Organic Carbon (TOC). The total denitrification of the NO(3)(-) generated along the chemical-biological treatment was achieved by means of the inclusion of a 24-h anoxic stage in the SBBR strategy. In addition, the Activated Sludge Model No. 1 (ASM1) was successfully used to complete the N balance determining the N fate in the SBBR. The characterization and the good performance of the SBBR allow presenting the assessed combination as an efficient way for the treatment of wastewaters contaminated with biorecalcitrant pharmaceuticals as the SMX.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app